Mode
Text Size
Log in / Sign up
N/A N=45 Randomized Double-blind Basic Science

Transcranial Magnetic Stimulation (TMS) for Motor Symptoms in Psychiatric Disorders

Psychomotor Retardation · Psychomotor Slowing · Schizophrenia and Related Disorders · Major Depressive Disorder

Enrolled (actual)
45
Serious AEs
2.3%
Results posted
May 2021
Primary outcome: Primary: Number of Responders at Week 3 — 4; 9; 0; 3 responders

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
DLPFC facilitatory (Other); SMA inhibitory (Other); SMA facilitatory (Other); sham TMS (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Bern
Primary completion
Jul 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Responders at Week 3
4; 9; 0; 3
SECONDARY
Change in Salpetriere Retardation Rating Scale Total Score From Baseline to Week 3
SECONDARY
Change in Activity Level From Baseline to Week 3
SECONDARY
Change in Catatonia Severity From Baseline to Week 3
SECONDARY
Change in Fingertapping Score From Baseline to Week 3
SECONDARY
Change in Coin Rotation From Baseline to Week 3
SECONDARY
Change in Hand Gesture Performance From Baseline to Week 3
SECONDARY
Change in SANS Total Score From Baseline to Week 3
SECONDARY
Change From HAMD Total Score From Baseline to Week 3
SECONDARY
Change in CAINS Total Score From Baseline to Week 3
SECONDARY
Change in PANSS Total and Subscores From Baseline to Week 3

Summary

Psychomotor slowing may occur in major psychiatric disorders, such as major depressive disorders or schizophrenia spectrum disorders. It refers to slowing of fine motor skills, motor planning and gross motor behavior. In major depression and schizophrenia, psychomotor slowing is associated with alterations of premotor cortex, dorsolateral prefrontal cortex and basal ganglia. This randomized, sham-controlled, prospective trial will test, whether 15 sessions of repetitive transcranial magnetic stimulation (rTMS) may ameliorate psychomotor slowing in schizophrenia or major depression.

Eligibility Criteria

Inclusion Criteria

  • suffering from major depressive disorder or schizophrenia spectrum disorder according to DSM-5 criteria
  • right handedness
  • normal or corrected-to-normal vision and hearing

Exclusion Criteria

  • epilepsy
  • history of severe head trauma
  • current abuse of drugs or alcohol; past addiction to drugs or alcohol
  • pregnancy
  • incompatibility to cerebral MRI
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03275766). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search